Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-19

Clinical Trial Update: Fish OIL Optimal dosE Determination Study [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the optimal dosing of fish oil for sepsis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil

Snippet

Sponsor: University Hospital Carl Gustav Carus | Conditions: Sepsis | Phase 2 | Status: TERMINATED